Nearly Two Decades Using the Check-Type to Prevent ABO-Incompatible Transfusions One Institution s Experience
|
|
- Oliver Stephens
- 6 years ago
- Views:
Transcription
1 Coagulation and Transfusion Medicine / CHECK-TYPE POLICY FOR ABO CONFIRMATION Nearly Two Decades Using the Check-Type to Prevent ABO-Incompatible Transfusions One Institution s Experience Priscilla I. Figueroa, MD, 1 Alyssa Ziman, MD, 2 Christine Wheeler, MD, 3 Jeffrey Gornbein, DrPH, 4 Michael Monson, 2 and Loni Calhoun, MT(ASCP)SBB 2 Key Words: Check type; ABO-incompatible transfusion; Specimen collection errors; Miscollected sample; Transfusion errors; Sample identification; Blood typing Abstract To detect miscollected (wrong blood in tube [WBIT]) samples, our institution requires a second independently drawn sample (check-type [CT]) on previously untyped, non group O patients who are likely to require transfusion. During the 17-year period addressed by this report, 94 WBIT errors were detected: 57% by comparison with a historic blood type, 7% by the CT, and 35% by other means. The CT averted 5 potential ABO-incompatible transfusions. Our corrected WBIT error rate is 1 in 3,713 for verified samples tested between 2000 and 2003, the period for which actual number of CTs performed was available. The estimated rate of WBIT for the 17-year period is 1 in 2,262 samples. ABO-incompatible transfusions due to WBIT-type errors are avoided by comparison of current blood type results with a historic type, and the CT is an effective way to create a historic type. Mistransfusion of ABO-incompatible blood poses a greater risk for transfusion recipients than the risk of transmission of infectious disease, accounting for 37% of all reported transfusion-associated fatalities in the United States. 1 Published reports cite an incidence of ABO discrepancy due to inappropriately identified specimens ranging from 1 in 517 to 1 in 3,400 samples. 2-4 Considering that approximately two thirds of transfused units will be ABOcompatible by chance alone and that the true incidence of transfusion errors has been estimated to be as high as 5 times the number of detected errors, the risk of mistransfusion may be severely underestimated. 5,6 The first step in preventing mistransfusion is obtaining blood for pretransfusion testing from the right patient and ensuring that all labeling is correct. Errors in these critical steps are recognized as the primary source of mistransfusion. Of greatest concern are the errors that cannot be identified by visual inspection of the samples and associated requisitions, whether in paper or electronic form. These miscollected blood samples (wrong blood in tube [WBIT]) in which tubes and requisitions appear properly labeled but the sample is drawn from a different patient are the stealthiest of errors and easily may go undetected until the event of an incompatible transfusion. According to a large multinational study involving 62 hospitals by Dzik et al 2 in 2003, WBIT accounts for up to 0.09% of samples collected. As a means of preventing ABO-incompatible transfusions due to WBIT-type errors, our institution has a policy of requiring a check-type (CT) sample a second independently drawn blood type sample on previously untyped non group O patients who require transfusion or are likely to require transfusion, including all patients admitted to labor and delivery, the 422 Am J Clin Pathol 2006;126: Downloaded 422 from
2 Coagulation and Transfusion Medicine / ORIGINAL ARTICLE operating room, or an intensive care unit for whom a request for type and screen (T&S) is received. Exception is made for trauma patients for whom a dual banding system is used as a means to prevent identification errors. To ensure independent specimen collection, the specimen must be collected into a prelabeled specimen tube generated by the blood bank after review of records indicates a need for a CT sample. The CT policy, in effect, creates a historic type when one does not exist. This article reviews our 17-year experience with the CT system. Materials and Methods All reports of mislabeled specimens detected between January 1987 and December 2003 were reviewed. These reports, summarized on a Blood Bank Specimen Labeling Error form, documented specimens and requisitions with any type of labeling error. From these, WBIT-type errors were identified based on the following: (1) discrepant ABO or Rh typing results between the implicated sample and the patient s historic record or CT sample, (2) the service having notified the blood bank that a specimen was mislabeled, and (3) irregularities not related to name, identification number, or blood type that raised suspicions about the identity of the sample. Discrepancies were resolved by retyping an additional sample drawn by a different staff member or at a different time from the implicated sample. Group O Rh blood was issued if the transfusion could not be delayed for retyping of an additional specimen. For each WBIT-type error, the following data were extracted from the Blood Bank Specimen Labeling Error forms and available follow-up documentation: location of collection; identity of responsible phlebotomist; initial (historic) blood type and discrepant blood type; how the error was found or identified; whether the miscollected specimen was the specimen requested as the CT, and if yes, whether it was collected in the blood bank generated prelabeled tube; and whether the miscollected specimen could have resulted in ABO and/or Rh incompatibility. Workload data, obtained through a computer query for applicable test codes, provided the number of T&S tests performed during the period. A true count of the number of CT tests performed was available only by computer query beginning in 2000 when a specific CT computer test code was created. Before 2000, CT tests were coded as ABO- Rh tests, and numbers of tests can only be estimated. By using the aforementioned information, we calculated the estimated true rate of WBIT corrected for the rate of verified samples and for the rate of silent errors by the method reported by Dzik et al. 2 The raw rate of WBIT was determined by using the ratio of the number of samples whose result did not match the previous record on the patient divided by the total number of samples for which a previous result was on record (verified samples). This rate then was corrected for silent WBIT errors, which can occur when the ABO group of the blood in the tube matches the ABO group on record although the wrong patient s blood is collected. The correction factor was based on the distribution of ABO groups in the University of California, Los Angeles (UCLA) patient population. Results Between January 2000 and December 2003, the time frame when T&S and CT numbers could be accurately counted, 107,835 T&S and 16,164 CT specimens were tested. Fifteen specimens were identified as miscollected (or WBIT-type errors). The rate of miscollected specimens (WBIT) between 2000 and 2003 with correction for silent errors was 1 in 3,713 (based on 15 WBITs of 80,026 verified samples with a correction factor of 1.437). Table 1 shows yearly corrected rates of WBIT for 2000 through 2003 and the number of specimens tested, verified (CT or historic type as part of a previous blood bank workup) and nonverified (group O patients and patients with only 1 blood type on record). Table 1 Rate of WBIT for Total T&S performed 26,553 26,864 26,808 27, ,835 Verified types 21,058 19,442 19,273 20,253 80,026 CT performed 3,212 4,256 4,342 4,354 16,164 Historic blood type available 17,684 15,186 14,931 15,899 63,862 Nonverified blood types 5,495 7,422 7,535 7,357 27,809 WBIT Raw WBIT rate 3,008 6,481 9,636 6,751 5,335 Corrected WBIT* Corrected WBIT rate* 2,094 4,510 6,706 4,698 3,713 CT, check type; T&S, type and screen; WBIT, wrong blood in tube. * Corrected for silent errors. Correction factor of (1 Q = 0.696). Based on blood group frequencies of the University of California, Los Angeles patient population: O Rh+, 44.23%; O Rh, 4.95%; A Rh+, 29.90%; A Rh, 4.13%; B Rh+, 11.63%; B Rh, 1.27%; AB Rh+, 3.47%; and AB Rh, 0.43%. Downloaded from Am J Clin Pathol 2006;126:
3 Figueroa et al / CHECK-TYPE POLICY FOR ABO CONFIRMATION During the 17-year period addressed by this report ( ), 411,705 T&Ss were performed and a total of 94 WBITtype errors were identified. Of 94 errors, 61 (65%) were detected by discrepant typing results (~57% by comparison with a historic blood type, ~7% by the CT), 26 (28%) when the clinical service informed the blood bank of the error, 3 (3%) by other specimen labeling errors (second label discovered under first, date of birth inconsistent with cord blood requests), and 4 (4%) by other means (eg, inquiry regarding a blood order or availability of blood products for a particular patient). Of the 61 WBIT-type errors detected by discrepant typing results, 27 cases (44%) could have resulted in an ABO-incompatible transfusion and 6 (10%) could have resulted in an Rhincompatible transfusion, representing 1.6 and 0.4 transfusions per year, respectively, at our institution. Of 61 discrepant results, 40 (66%) were detected by comparing the current type with an established historic blood type. Of these, 14 initially typed as O Rh+ and 8 as O Rh. Of the O Rh+ types, 12 subsequently were shown to be non group O, and 4 were shown to be truly Rh. Of the O Rh types, 5 later were shown to be non group O, and only 1 was truly Rh. The remaining 21 (34%) of 61 discrepant samples were detected by comparing the type of the CT sample with the T&S sample. In 7 of these (11% of all discrepant typings and 33% of discrepancies involving a CT), the CT sample revealed an incorrect initial T&S sample. Transfusion based on the initial sample would have resulted in an ABO-incompatible transfusion in 5 of 7 cases. Of the remaining 14 cases involving a CT sample (23% of all discrepant typings, 66% of those involving a CT sample), the prelabeled blood bank generated CT sample was the miscollected sample. All WBIT-type errors were attributed to personnel not adhering to patient identification protocols. In 85 cases (90%), the identification error occurred at the time of phlebotomy. In 9 cases (10%), the identification error occurred at the time of patient admission or registration. Samples involving WBITtype errors were drawn from patients in all inpatient and outpatient areas; non intensive care unit inpatient units and labor and delivery had a disproportionately high number of occurrences Table 2. Personnel responsible for obtaining the samples involved in the 94 WBIT-type errors included the following: nurses, 45 (48%); phlebotomists, 26 (28%); physicians, 19 (20%); clinical partners (noncredentialed nursing-affiliated staff), 3 (3%); and medical student, 1 (1%). Discussion Most ABO-incompatible transfusions result not from laboratory errors but from mistakes in patient identification, including sample labeling errors that result in the wrong blood collected in the tube or misidentification of the patient at the time of Table 2 Location of Specimen Collections for 94 Wrong Blood in Tube Errors No. (%) of Sites of Distribution of Specimen Location Miscollected Specimens Collection at UCLA (%) Inpatient units 59 (63) 38.8 Delivery room 11 (12) 2.5 Intensive care units 8 (9) 18.4 Outpatient clinics 7 (7) 20.2 Outpatient laboratory 4 (4) 3.0 Operating rooms 3 (3) 13.6 Emergency department 2 (2) 3.4 UCLA, University of California, Los Angeles. transfusion. The risk of ABO-incompatible transfusion is estimated to be 3 times greater than the combined risks of transfusion transmission of hepatitis B, hepatitis C, and HIV. 1 This high risk is receiving increasingly greater attention from the blood banking community and the public. As of December 29, 2004, the College of American Pathologists Transfusion Medicine Checklist has required that facilities have a documented program to ensure that the risk of pretransfusion sample misidentification is monitored and subjected to continual process improvement (TRM.30550, phase II). Methods of compliance provided in the checklist include the following: (1) obtaining a second separately collected sample for repeated ABO grouping, (2) mechanical barrier or electronic identification verification systems, (3) issuing only group O units for transfusion, and (4) documentation in laboratory records of a previous ABO determination from a correctly labeled specimen. The UCLA CT policy, which satisfies examples 1 and 4 of the College of American Pathologists requirement, was instituted in an effort to prevent ABO-incompatible transfusions resulting from miscollected specimens. Our data represent the longest experience using a check-type system reported by a US institution. Our WBIT-type error rate corrected for silent errors is 1 in 3,713 for verified samples submitted for pretransfusion testing between 2000 and Based on the data and the total number of WBIT errors detected between 1987 and 2003, we estimate that the rate of WBIT during the 17-year period was 1 in 2,262 samples tested (based on 94 WBIT errors of an estimated 305,532 verified samples [using the ratio of verified specimens/t&ss performed between 2000 and 2003]) with a silent error correction factor of Because our CT policy is applicable only to patients who are likely to require transfusion and do not initially type as group O, this number underestimates the incidence of WBIT-type errors at our institution. Chiaroni et al 4 reported the use of a similar system applied across all blood groups by a laboratory performing pretransfusion testing for 35 French hospitals. As in our study, ABO discrepancies were detected by comparing 2 current 424 Am J Clin Pathol 2006;126: Downloaded 424 from
4 Coagulation and Transfusion Medicine / ORIGINAL ARTICLE blood types or 1 current blood type and a historic type. 4 They demonstrated that during a 5-year period (September 1998 to July 2003), the incidence of ABO discrepancies was 1 per 3,400 tests performed. In their experience, most discrepancies (58%) were secondary to phlebotomy errors in which the sample was obtained from the wrong patient, whereas the second most common cause of discrepancy was error during patient registration or identification (30%). In comparison, 90% of our errors were due to patient identification at the time of phlebotomy, and only 10% were due to admission or registration errors. During the 17-year period ( ), our policy of requiring 2 independent samples for blood typing before issuing type-specific blood for non group-o patients potentially averted an estimated 1.6 incompatible transfusions per year at our institution. In the majority of cases, the 2-sample requirement was met by having a historic type on record, but when no historic type was available, the CT sample was an effective means of establishing a historic type. The CT sample detected an incorrect initial type in 11% of phlebotomy errors (potentially averting 5 ABO-incompatible transfusions). In an additional 23% of phlebotomy errors, the CT itself was the source of error. These CT samples were miscollected in the prelabeled blood bank generated CT specimen tubes, raising the question of whether this practice alone increases the risk of miscollected samples. Given 2 known WBIT-type errors in 31,806 CTs collected between 2000 and 2003 (0.0629%), and 14 errors from an estimated 121,433 CT samples (0.0115%) obtained during the 17-year period, UCLA continues to use the prelabeled tube system. We have concluded that the inconvenience and cost of needing to draw a third specimen owing to a WBIT error involving the CT sample is small relative to the risk incurred when staff, through lack of knowledge or deliberate noncompliance, draw the CT sample at the same time as the initial specimen. The CT policy seems to be a cost-effective approach for reducing WBIT-type errors, especially, if legal costs are considered. A recent cost analysis for a CT drawn by a phlebotomist at our institution was $2.39, resulting in costs of approximately $20,000 per year. Although several other innovations have been developed to address this problem and reduce transfusion errors, including mechanical barrier systems, unique transfusion identification numbers with or without barcode scanning, and radiofrequency scanners that read information encoded on chips on blood units and patient identification bands, they are much more costly For example, AuBuchon and Littenberg 16 concluded that a mechanical barrier system could be cost-effective, if legal costs were considered, and that such a system was successful in reducing the risk of fatal acute hemolytic transfusion reactions due to mistransfusion by more than 99.99%. A mechanical barrier such as the Bloodloc Safety System (Novatek Medical, Altamont, IL) would cost our institution $100,408 to $133,878 per year based on 234,286 RBC units transfused from 1998 through 2004 (each with locks costing between $3.00 and $4.00 per unit). 9 Another proposed safety measure involves barcoded labels with a unique transfusion identification number attached to the patient s wristband, the sample tubes, blood request, and compatible blood units, which at the time of transfusion are scanned with a portable barcode scanner to verify the match between patient identification and the blood unit. UCLA recently studied the feasibility of implementing such a system; a quote obtained from a leading manufacturer was approximately $200,000 for 20 users including 1 year of technical support. The disadvantages of requiring 2 independent blood samples before issuing type-specific blood include costs, inconvenience to the patient and patient care services, potential delays in providing blood, and possible increased use of group O blood. In addition, when the requirement for type confirmation is limited to non group O samples, the risk of Rh-incompatible transfusion remains. The extent to which these disadvantages may be minimized depends on the degree of institutional support for a second sample (CT) policy, which in turn is dependent on the effectiveness of educational campaigns to increase awareness about ABO transfusion errors. Perhaps the most effective policy for patient safety and convenience is one that rather than deferring all blood typing until transfusion is probable, requires establishing a historic blood type as part of the patient s medical record. The financial impact of such a policy could be minimized by targeting patients with greater risk of requiring blood transfusion (eg, patients requiring surgery, patients with hematologic or oncologic disorders or gastrointestinal bleeding, and geriatric patients), by obtaining blood type samples with other routine laboratory blood samples, and by batch testing these typings. Avoidance of ABO-incompatible transfusion and detection of WBIT-type errors in the absence of reliable electronic methods for bedside patient identification depends primarily on comparison of current blood type results with a historic type. Therefore, until such technology is implemented, the use of the CT, although subject to erroneous collection itself, seems to be an effective and relatively inexpensive method for detecting errors in blood sample collection and is an additional means of preventing ABO-incompatible transfusions by creating a historic type. From the Departments of Pathology and Laboratory Medicine, 1 the Cleveland Clinic, Cleveland, OH; 2 Division of Transfusion Medicine, University of California, Los Angeles; 3 University of California, Irvine; and the 4 Department of Biomathematics, University of California, Los Angeles. Address reprint requests to Dr Figueroa: Cleveland Clinic, Section of Transfusion Medicine, Desk L20, 9500 Euclid Ave, Cleveland, OH Downloaded from Am J Clin Pathol 2006;126:
5 Figueroa et al / CHECK-TYPE POLICY FOR ABO CONFIRMATION Acknowledgments: We thank and acknowledge the assistance of Rebecca Davis, MT(ASCP), Tracey Allen, MT(ASCP)SBB, Marianne Silva, MS, MT(ASCP)SBB, CQA(ASQ), Mary Anne Anthony, MT(ASCP)SBB, and Carma Lizza for their support and help in obtaining the data for this study. References 1. Aubuchon JP, Kruskall MS. Transfusion safety: realigning efforts with risks. Transfusion. 1997;37: Dzik WH, Murphy MF, Andreu G, et al. An international study of the performance of sample collection from patients. Vox Sang. 2003;85: Murphy MF, Steam BE, Dzik WH. Current performance of patient sample collection in the UK. Transfus Med. 2004;14: Chiaroni J, Legrand D, Dettori I, et al. Analysis of ABO discrepancies occurring in 35 French hospitals. Transfusion. 2004;44: Ibojie J, Urbaniak SJ. Comparing near misses with actual mistransfusion events: a more accurate reflection of transfusion errors. Br J Haematol. 2000;108: Callum JL, Kaplan HS, Merkley LL, et al. Reporting of nearmiss events for transfusion medicine: improving transfusion safety. Transfusion. 2001;41: Marconi M, Sirchia G. Increasing transfusion safety by reducing human error. Curr Opin Hematol. 2000;7: Lau FY, Wong R, Chui CH, et al. Improvement in transfusion safety using a specially designed transfusion wristband. Transfus Med. 2000;10: US Food and Drug Administration. Best practices for reducing transfusion errors: OBRR/CBER/FDA Workshop. February 14, Available at bloo.htm. Accessed July 25, Dzik WH, Corwin H, Goodnough LT, et al. Patient safety and blood transfusion: new solutions. Transfus Med Rev. 2003;17: Discussion paper of the American Association of Blood Banks for the 2nd National Summit on Patient Safety Research. November 7, Available at Members_Area/Members_Area_Regulatory/Patient_Safety/pss htm. Accessed July 25, Wenz B, Burns ER. Improvement in transfusion safety using a new blood unit and patient identification system as part of safe transfusion practice. Transfusion. 1991;31: Mercuriali F, Inghilleri G, Colotti MT, et al. One-year use of the Bloodloc system in an orthopedic institute. Transfus Clin Biol. 1994;1: Mercuriali F, Inghilleri G, Colotti MT, et al. Bedside transfusion errors: analysis of 2 years use of a system to monitor and prevent transfusion errors. Vox Sang. 1996;70: Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion. 1992;32: AuBuchon JP, Littenberg B. A cost-effectiveness analysis of the use of a mechanical barrier system to reduce the risk of mistransfusion. Transfusion. 1996;36: Ehrlich A. Simple method helps to detect transfusion medicine errors. Hospitals. September 1976;50: Jensen NJ, Crosson JT. An automated system for bedside verification of the match between patient identification and blood unit identification. Transfusion. 1996;36: Marconi M, Langeberg AF, Sirchia G, et al. Improving transfusion safety by electronic identification of patients, blood samples and blood units. Immunohematology. 2000;16: Turner CL, Casbard AC, Murphy MF. Barcode technology: its role in increasing the safety of blood transfusion. Transfusion. 2003;43: Am J Clin Pathol 2006;126: Downloaded 426 from
The Group Check. Jeannie Callum, BA, MD, FRCPC, CTBS
The Group Check Jeannie Callum, BA, MD, FRCPC, CTBS Outline Our perception of the health care employees that make sample collection errors Brief review of the medical literature on sample collection errors
More informationChanges in practice and organisation surrounding blood transfusion in NHS trusts in England
See Commentary, p 236 1 National Blood Service, Birmingham, UK; 2 National Blood Service, Oxford, UK; 3 Clinical Evaluation and Effectiveness Unit, Royal College of Physicians, London, UK Correspondence
More informationNEW ABO 2 Sample Protocol. Reducing the Risk to Mistransfusion
NEW ABO 2 Sample Protocol Reducing the Risk to Mistransfusion Thank You Dr.Charles Musuka MBChB, FRCPC, FRCPath Haematopathologist and Medical Director DSM Transfusion Medicine Brenda Herdman Technical
More informationThe successful transfusion of blood products is dependent
Designing Safer Systems Enhancing Transfusion Safety with an Innovative Bar-Code-Based Tracking System Ryan W. Askeland, Steve P. McGrane, Dan R. Reifert and John D. Kemp Abstract In an effort to reduce
More informationObjectives. With the completion of this module the learner will:
Specimen Labeling Objectives With the completion of this module the learner will: Identify the appropriate procedure for collecting and labeling specimens. Define patient identification requirements at
More informationTrauma is the leading cause of death in individuals
HOW DO I...? How do we provide blood products to trauma patients? Shan Yuan, Alyssa Ziman, Mary Anne Anthony, Elsa Tsukahara, Courtney Hopkins, Qun Lu, and Dennis Goldfinger Trauma is the leading cause
More informationPretransfusion Testing Specimen Collection TRAINING GUIDE TM T-08
Pretransfusion Testing Specimen Collection TRAINING GUIDE TM T-08 TABLE OF CONTENTS OVERVIEW... 3 LEARNING OBJECTIVES... 3 SCOPE... 3 DEFINITIONS... 3 ROLES AND RESPONSIBILITIES... 4 PROCEDURE INSTRUCTIONS...
More informationCLINICAL CHEMISTRY. Phone: The department is staffed 24 hours a day.
CLINICAL CHEMISTRY Phone: 922-4488 Hours: The department is staffed 24 hours a day. Monday Friday Saturday Sunday Days: 8:00 a.m. - 4:30 p.m. Full Testing Limited Limited Evenings: 4:00 p.m. - 12:30 a.m.
More informationB LABELING AND COLLECTION OF SPECIMENS FOR BLOOD BANK
Effective Date: 12/17/2014 LABELING AND COLLECTION OF SPECIMENS FOR BLOOD BANK 1.0 Principle Proper identification of patient, patient s sample and blood products is crucial to safe transfusion. A correctly
More informationPATIENT SAFETY/ORIGINAL RESEARCH
PATIENT SAFETY/ORIGINAL RESEARCH Significant Reduction of Laboratory Specimen Labeling Errors by Implementation of an Electronic Ordering System Paired With a Bar-Code Specimen Labeling Process Peter M.
More informationWristband Errors in Small Hospitals
PHLEBOTOMY J a n e C. Dale, MD Stephen W. Renner, MD Wristband Errors in Small Hospitals A College of American Pathologists' Q-Probes Study of Quality ssues in Patient dentification Although methods of
More informationPreanalytical Errors in Laboratory - Their Consequences and Measures to Reduce Them
Preanalytical Errors in Laboratory - Their Consequences and Measures to Reduce Them Tazeen Farooqui, Student of MBA (HM), College of Hospital Administration, TMU, Moradabad Email:-tazeenfarooqui01@gmail.com
More informationIHI Expedition. Today s Host 9/17/2014
September 6, 204 Begins at 3:00 PM EST These presenters have nothing to disclose IHI Expedition Expedition: Appropriate Use of Blood Products Session 3: Transfusion Safety Program Infrastructure: Measures
More informationSUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure
SUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure Subject: BLB 1 Procedures for Ordering Picking-up and Delivery of Blood Prepared By:
More informationThe Importance of Transfusion Error Surveillance This is step #1 in error management. Jeannie Callum, BA, MD, FRCPC, CTBS
The Importance of Transfusion Error Surveillance This is step #1 in error management Jeannie Callum, BA, MD, FRCPC, CTBS 6051 Clinical Errors 9083 Laboratory Errors 15134 Errors over 6 years I don t want
More informationSample. A guide to development of a hospital blood transfusion Policy at the hospital level. Effective from April Hospital Transfusion Committee
Sample A guide to development of a hospital blood transfusion Policy at the hospital level Name of Policy Blood Transfusion Policy Effective from April 2009 Approved by Hospital Transfusion Committee A
More informationBenefiting from Bedside Specimen Labeling
Benefiting from Bedside Specimen Labeling Labeling blood and other samples at the time they are collected improves patient safety and helps prevent a host of problems related to misidentification including
More informationMEETING. of Transfusion Service Information
Second Integration Annual or Pathology Disintegration All Staff MEETING of Transfusion Service Information Suzanne H. Butch, MLS(ASCP) CM, SBB CM, DLM CM University of Michigan Hospitals and Health Centers
More information2/15/2017. Reducing Mislabeled and Unlabeled Specimens In Acuity Adaptable Units
Reducing Mislabeled and Unlabeled Specimens In Acuity Adaptable Units Jennifer Kitchens MSN, RN, ACNS-BC, CVRN Clinical Nurse Specialist Acuity Adaptable Esther Onuorah, MSN, RN, CMSRN Staff Nurse Acuity
More informationLessons for Transfusion Laboratory Staff. from the 2007 SHOT Report SHOT SERIOUS HAZARDS OF TRANSFUSION
Lessons for Transfusion Laboratory Staff from the 2007 SHOT Report SERIOUS HAZARDS OF TRANSFUSION SHOT The Serious Hazards of Transfusion Scheme (SHOT) is a UK-wide confidential enquiry that collects data
More informationFitting Automation into a Small Transfusion Service
Fitting Automation into a Small Transfusion Service Jo Bruner, MLS (ASCP) CM Blood Bank, Hematology & Coagulation Section Head Fulton County Health Center Laboratory Objectives - List the advantages and
More informationHAEMOVIGILANCE. Ms. Emma O Riordan Haemovigilance, CNM2 (Acting) Ms. Bríd Doyle, MSc. FAMLS. Haemovigilance Co-ordinator, (Acting)
HAEMOVIGILANCE a set of surveillance procedures covering the whole transfusion chain from the collection of blood and its components to the follow-up of its recipients, intended to collect and assess information
More information7 th Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration
7 th Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration Summary of Changes This document summarizes the major changes made
More informationBIOMETRICS IN HEALTH CARE : A VALUE PROPOSITION FROM HEALTH CARE SECTOR
UMANICK TECHNOLOGIES, S.L. www.umanick.com info@umanick.com 1 / 7 Introduction In any country s health care system, many challenges have yet to be resolved. And patient identification is perhaps the greatest
More informationSAFE PRACTICE 14: LABELING DIAGNOSTIC STUDIES
Safe Practices for Better Healthcare 2010 Update SAFE PRACTICE 14: LABELING DIAGNOSTIC STUDIES The Objective Reduce the risk of misinterpretation of radiology, laboratory, and pathology studies due to
More informationWelcome to. Patient Identification and Transfusion Safety: Six years of Experience with Bar Code Scanning. March 24, 2011.
Welcome to Patient Identification and Transfusion Safety: Six years of Experience with Bar Code Scanning March 24, 2011 Copyright, The Joint Commission Patient Identification and Transfusion Safety: Six
More informationCan a barcode scanner for blood collection improve patient identification integrity in the emergency department? A prospective before-andafter
Bond University epublications@bond Faculty of Health Sciences & Medicine Publications Faculty of Health Sciences & Medicine 11-2-2015 Can a barcode scanner for blood collection improve patient identification
More informationSTANDARD OPERATING PROCEDURE FOR PATIENT HISTORY CHECK
STANDARD OPERATING PROCEDURE FOR PATIENT HISTORY CHECK 1.0 Principle 1.1 To review current patient results with previous records for possible discrepancies to check for special instructions or comments
More informationLaboratory Services. Specimen Collection & Rejection Procedure
Laboratory Services Specimen Collection & Rejection Procedure According to both the Clinical Laboratory Improvement Amendment (CLIA) regulations and the College of American Pathologist s (CAP) Accreditation
More informationThe Transfusion Medicine diplomate will respect the rights of the individual and family and must
Competency Portfolio for the Diploma in Transfusion Medicine Guide for AFC-Diploma Committees/Working Groups, Educators 2012 VERSION 1.0 This portfolio applies to those who begin training on or after July
More informationLaboratory Request Form Completion and Specimen Labelling Reference Number:
This is an official Northern Trust policy and should not be edited in any way Laboratory Request Form Completion and Specimen Labelling Reference Number: NHSCT/12/582 Target audience: This policy is directed
More informationPOLICY NO.: POLICY AND PROCEDURE Subject: Patient Identification and Wrist Bands SUPERSEDES: ORIGINAL DATE: PAGE: I. POLICY: II. DEFINITIONS: PC_01
POLICY AND PROCEDURE Subject: Patient Identification and Wrist Bands POLICY NO.: PC_01 ORIGINAL DATE: SUPERSEDES: PAGE: 04/01/1998 12/2012 1 of 6 Key Words: Color Coded Alert, ID Applies to: Inpatient:
More informationINPATIENT Annual Core Competency Performance Stations (Nursing) 2010 (Unlicensed Staff Direct & Non-Direct Care Providers * )
County of Los Angeles INPATIENT Annual Core Competency Performance Stations (Nursing) 2010 (Unlicensed Staff Direct & Non-Direct Care Providers * ) * Staff who work in patient care areas 1 ANNUAL CORE
More informationREVISED: 7/03, 03/05, 04/08, 3/10, 11/11, 09/13, 3/14,1/15, 4/16
TITLE/DESCRIPTION: DEPARTMENT: PERSONNEL: BLOOD PRODUCT ADMINISTRATION CLINICAL LABORATORY ALL HOSPITAL EMPLOYEES EFFECTIVE DATE: 10/95 REVISED: 7/03, 03/05, 04/08, 3/10, 11/11, 09/13, 3/14,1/15, 4/16
More informationDisclosure. I have no conflict of interest with this event because I have no affiliations, sponsorships, honoraria, monetary support or conflict of
The RBC Audit: What s in your closet? Yulia Lin, MD, FRCPC Transfusion Medicine & Hematology, Sunnybrook HSC Assistant Professor, Dept of LMP, University of Toronto On behalf of the RBC Audit Working Group
More informationClinical Laboratories West Virginia University Hospitals. Resident Orientation
Clinical Laboratories West Virginia University Hospitals Resident Orientation Peter L. Perrotta, MD Medical Director Clinical Laboratories pperrotta@hsc.wvu.edu Joseph A. DelTondo, DO Director of Autopsy
More informationA Guide To Safe Blood Transfusion Practice
A Guide To Safe Blood Transfusion Practice Introduction To Blood Transfusion Safety Marie Browett, Pavlina Sharp, Fiona Waller, Hafiz Qureshi, Malcolm Chambers (on behalf of the UHL Blood Transfusion Team)
More informationBlood Sample Labeling Shean Strong, QI Director Lisle Mukai, QI Coordinator
Blood Sample Labeling Shean Strong, QI Director Lisle Mukai, QI Coordinator Presented at Webex Conferences: July 20, 21, & 22, 2010 Blood Sample Labeling Seminar 6255 West Sunset Blvd Los Angeles, CA Blood
More informationTitle: VERIFICATION OF PROCEDURES TO BE PERFORMED
Approved By: Garren Colvin, EVP/COO Responsible Parties: Alicia Humphrey, Director Outpatient Surgery Tracie Shelton, Director Patient Safety & Accreditation Policy No.: ACLIN-V-01 Originated: 01/01/11
More informationDOCUMENT CONTROL Patient Identification Policy 6 CL001
Title: Version: Reference Number: Scope: DOCUMENT CONTROL Patient Identification Policy 6 CL001 This policy applies to all staff who work in an inpatient setting and staff accessing inpatient wards. Purpose:
More informationSUNY DOWNSTATE MEDICAL CENTER UNIVERSITY HOSPITAL OF BROOKLYN POLICY AND PROCEDURE
SUNY DOWNSTATE MEDICAL CENTER UNIVERSITY HOSPITAL OF BROOKLYN POLICY AND PROCEDURE No: LAB-1 Subject: PROCEDURES FOR HANDLING Page 1 of 6 INPATIENT AND OUTPATIENT LABORATORY Prepared by: Dynesdal Wint
More informationCLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS
CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS RATIONALE All Professionals/healthcare workers are personally accountable for their practice and, in the exercise of their professional accountability,
More informationPreventing Medical Errors
Presents Preventing Medical Errors Contact Hours: 2 First Published: March 31, 2017 This Course Expires on: March 31, 2019 Course Objectives Upon completion of this course, the nurse will be able to: 1.
More informationPolicy for Patient Identification. Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled Document Lead:
CONTROLLED DOCUMENT Policy for Patient Identification CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 3 Controlled Document Sponsor: Controlled Document Lead: Approved By:
More informationSetting up an Anticoagulation Clinic in Primary Care. Contents
Setting up an Anticoagulation Clinic in Primary Care This paper aims to outline the decisions and practical steps needed to set up and run a successful anticoagulation clinic in a primary care setting.
More informationFREQUENTLY ASKED QUESTIONS (FAQS) FOR THE INDIVIDUAL HEALTH IDENTIFIER (IHI) JANUARY 2016
FREQUENTLY ASKED QUESTIONS (FAQS) FOR THE INDIVIDUAL HEALTH IDENTIFIER (IHI) JANUARY 2016 IHI FAQs Version 11.0. 28 January 2016 TABLE OF CONTENTS 1. What is an Individual Health Identifier or IHI?...4
More informationRoot-Cause Analysis of a Potentially Sentinel Transfusion Event: Lessons for Improvement of Patient Safety
ORIGINAL REPORT Root-Cause Analysis of a Potentially Sentinel Transfusion Event: Lessons for Improvement of Patient Safety Hossein Adibi 1, Nader Khalesi 1, Hamid Ravaghi 1, Mahdi Jafari 1, and Ali Reza
More informationExploring the Initial Steps of the Testing Process: Frequency and Nature of Pre-Preanalytic Errors
Clinical Chemistry 58:3 638 642 (2012) Laboratory Management Exploring the Initial Steps of the Testing Process: Frequency and Nature of Pre-Preanalytic Errors Paolo Carraro, Tatiana Zago, and Mario Plebani
More informationMartin Health System Stuart, Florida Laboratory Services. Laboratory Services and Policies
Martin Health System Stuart, Florida Laboratory Services Laboratory Services and Policies Service Commitment: It is the goal of the Martin Health System s Clinical Laboratory to provide the medical community
More informationuality Management Tools
www.cap.org uality Management Tools The CAP s comprehensive collection of Quality Management Tools (QMT) strengthens your knowledge of key laboratory processes, identifies quality improvement opportunities,
More informationPopulation and Sampling Specifications
Mat erial inside brac ket s ( [ and ] ) is new to t his Specific ati ons Manual versi on. Introduction Population Population and Sampling Specifications Defining the population is the first step to estimate
More informationFrom customer satisfaction survey to corrective actions in laboratory services in a university hospital
International Journal for Quality in Health Care 2006; Volume 18, Number 6: pp. 422 428 Advance Access Publication: 26 September 2006 From customer satisfaction survey to corrective actions in laboratory
More informationFinancial Disclosure. Learning Objectives: Preventing and Responding to Sentinel Events in Surgery 10/13/2015
Preventing and Responding to Sentinel Events in Surgery Beverly Kirchner, BSN, RN, CNOR, CASC April 2014 Financial Disclosure I DO NOT have an actual, potential or perceived conflict of interest to disclose
More informationAuckland District Health Board Summary 1 July 2011 to 30 June 2012 Serious and Sentinel Events
DHB SSE Report 0 Auckland District Health Board Summary July 0 to 30 June 0 Serious and Sentinel Events There were 60 serious and sentinel events reported by ADHB in the July 0 to June 0 year. Events identified
More informationScope of Service. Department Mission
Scope of Service Department Mission Scope of Services Provided The Department of Laboratory Services provides a wide array of testing and other services to Memorial Health System s patients, and to other
More informationAccreditation Program: Office-Based Surgery
ccreditation Program: Office-Based Surgery National Patient Safety Goals indicates scoring category ; indicates scoring category ; indicates situational decision rules apply; indicates 2009 The Joint ommission
More informationDisclosures. Relevant Financial Relationship(s): Nothing to Disclose. Off Label Usage: Nothing to Disclose 6/1/2017. Quality Indicators
Laurie Griesmann, Quality Specialist May 17, 2017 Disclosures Relevant Financial Relationship(s): Nothing to Disclose Off Label Usage: Nothing to Disclose 1 Objectives Define a quality indicator. Recognize
More informationIdentification of Patient, Resident or Client Using Two Identifiers
Approved by: Vice President & Chief Medical Officer; and Vice President & Chief Operating Officer Identification of Patient, Resident or Client Using Two Corporate Policy & Procedures Manual Date Approved
More informationDESCRIPTION/OVERVIEW This document standardizes the transfusion of packed red blood cells and/or other blood components.
Applies To: UNM Hospitals & UNMCC Responsible Department: Blood Bank Revised: 5/2017 Procedure Patient Age Group: ( ) N/A (X) All Ages ( ) Newborns ( ) Pediatric ( ) Adult DESCRIPTION/OVERVIEW This document
More informationCHAPTER 5: SUBMISSION AND CORRECTION OF THE MDS ASSESSMENTS
CHAPTER 5: SUBMISSION AND CORRECTION OF THE MDS ASSESSMENTS Nursing homes are required to submit Omnibus Budget Reconciliation Act required (OBRA) MDS records for all residents in Medicare- or Medicaid-certified
More informationA Team Approach To Decrease Wasted Blood Products
QUALITY IMPROVEMENT Leigh Jefferies, MD M. Elizabeth Smith, MT(ASCP)SBB Deborah Magee, MT(ASCP)SBB Patricia Wallace, MSN, RN, CCRN Meg Horgan, MSN, RN A Team Approach To Decrease Wasted Blood Products
More informationPatient Safety It All Starts with Positive Patient Identity APRIL 14, 2016
Patient Safety It All Starts with Positive Patient Identity APRIL 14, 2016 Maximizing patient safety and improving the quality of care is the ultimate goal for healthcare providers. Doing so requires staying
More information2014 ANCC National Magnet Conference. Safeguarding Valuable Resources through Partnership, Technology, and Education
2014 ANCC National Magnet Conference Safeguarding Valuable Resources through Partnership, Technology, and Education Session # C707, 8:00AM 9:00AM Friday, October 10, 2014 Michelle L. Kopp, RN, MSN, AOCNS,
More informationDocument Number: QAQC.81.Proc Manual: Quality Assurance Quality Control. Version: 002 Publish Date: March 2013
Document Number: QAQC.81.Proc Manual: Quality Assurance Quality Control Version: 002 Publish March 2013 Positive patient identification (ld) is the crucial first step to ensuring patient safety in the
More informationCHAPTER 5: SUBMISSION AND CORRECTION OF THE MDS ASSESSMENTS
CHAPTER 5: SUBMISSION AND CORRECTION OF THE MDS ASSESSMENTS Nursing homes are required to submit MDS records for all residents in Medicare- or Medicaidcertified beds regardless of the pay source. Skilled
More informationStandards, Guidelines, and Regulations
Standards, Guidelines, and Regulations Theresa C. Stec BA, MT(ASCP) Biovigilance Program Manager Surgical System Administrator Perioperative Services Baystate Medical Center Springfield, MA Standards,
More informationAssessment criteria for obtaining a venous blood sample
Core blood competencies assessment framework Assessment criteria for obtaining a venous blood sample This framework is for assessing the candidates ability in obtaining a venous blood sample for transfusion.
More informationLABORATORY SPECIMEN ID REPORT FEBRUARY 2018
LABORATORY SPECIMEN ID REPORT FEBRUARY 2018 LABORATORY SPECIMEN ID REPORT 3 CONTENTS I. Executive Summary... 4 II. Survey Demographics... 5 III. Response Analysis a. Laboratory Priorities... 6 b. Specimen
More informationNational Patient Safety Goals Effective January 1, 2016
National Patient Safety Goals Effective January 1, 2016 Goal 1 Improve the accuracy of patient identification. NPSG.01.01.01 Office-Based Surgery ccreditation Program Use at least two patient identifiers
More informationNational Patient Safety Goals
III. PATIENT SAFETY National Patient Safety Goals The National Patient Safety Goals for Hospital, Laboratory and Home Health Programs have been developed to improve patient safety. Ask your Volunteer Office
More informationCOPY. That all specimens received by the lab are properly labeled by person collecting the specimen
Current Status: Active PolicyStat ID: 3609063 Origination: 07/2015 Last Approved: 11/2017 Last Revised: 07/2015 Next Review: 11/2019 Owner: Anne Harr: Supervisor, Lab Support Svc Policy Area: PCS: Pathology
More informationMGH Research Lab Orders Date: 08/10/2016
MGH Research Lab Orders Date: 08/10/2016 Try It Out MGH Ordering Research Labs A. Research Coordinator Draws Blood (for Research) Scenario #1- No SQ printer and No Clinical Visit MGH Lab processing and
More informationCME/SAM. Determination of Turnaround Time in the Clinical Laboratory
Clinical Chemistry / Turnaround Time in a Clinical Laboratory Determination of Turnaround Time in the Clinical Laboratory Accessioning-to-Result Time Does Not Always Accurately Reflect Laboratory Performance
More informationPolicy Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail MISSION STATEMENT: OVERVIEW:
Subject Objectives and Organization Pathology and Laboratory Medicine Index Number Lab-0175 Section Laboratory Subsection General Category Departmental Contact Ekern, Nancy L Last Revised 10/25/2016 References
More informationPatient Satisfaction in Phlebotomy
PHLEBOTOMY JaneC. Dale, MD Peter J. Howanitz, MD Patient Satisfaction in Phlebotomy A College of American Pathologists' Q-Probes Study From the Department of Laboratory Medicine and Pathology, Mayo Clinic,
More informationPRESENTERS: Cindy Cassity, RN, BSN, CPPS Allen Stanton, MT, DLM (ASCP) BAYLOR UNIVERSITY MEDICAL CENTER DALLAS, TEXAS OCTOBER 24, 2017
Creating and Sustaining the Culture of Patient Safety Through Interdisciplinary Collaboration PRESENTERS: Cindy Cassity, RN, BSN, CPPS Allen Stanton, MT, DLM (ASCP) BAYLOR UNIVERSITY MEDICAL CENTER DALLAS,
More informationTitle: Massive Transfusion Event Protocol Policy: Clinical Manual/General Clinical
Title: Massive Transfusion Event Protocol Policy: Manual/General I. POLICY: Massive Transfusion Event (MTE) Protocol: The MTE Protocol is initiated at the request of the anesthesiologist, surgeon or physician
More informationGENERAL ADMINISTRATIVE POLICY: ADVERSE EVENT REPORTING TO CALIFORNIA DEPARTMENT OF PUBLIC HEALTH (CDPH)
GENERAL ADMINISTRATIVE POLICY: ADVERSE EVENT REPORTING TO CALIFORNIA DEPARTMENT OF PUBLIC HEALTH (CDPH) Effective Date: 02/12 Page No. 1 of 7 I. PURPOSE To comply with mandated reporting requirements of
More informationCOMMISSION ON LABORATORY ACCREDITATION. Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST
Revised: 09/27/2007 COMMISSION ON LABORATORY ACCREDITATION Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST Disclaimer and Copyright Notice The College of American
More informationCommon Errors on the T3010 related to fundraising costs. Know how to avoid them
Common Errors on the T3010 related to fundraising costs Know how to avoid them 1 Focus of presentation Many errors that charities make in the reporting of their fundraising expenses on the T3010 occur
More informationWalking the Tightrope with a Safety Net Blood Transfusion Process FMEA
Walking the Tightrope with a Safety Net Blood Transfusion Process FMEA AnMed Health AnMed Health, located in Anderson, South Carolina, is one of the largest and most technologically advanced health systems
More informationSAFE ADMINISTRATION OF BLOOD COMPONENTS
SAFE ADMINISTRATION OF BLOOD COMPONENTS Dra. Cristina Sanz Department of Hemotherapy and Hemostasis Hospital Clinic, Barcelona, Spain. Peter McIntyre, Blood transfusion in desert dressing station, c.1941-1943
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE TRANSFUSION OF BLOOD COMPONENTS AND PRODUCTS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Transfusion Medicine Network Not applicable DOCUMENT #
More informationThe introduction of the first freestanding ambulatory
Epidemiology of Ambulatory Anesthesia for Children in the United States: and 1996 Jennifer A. Rabbitts, MB, ChB,* Cornelius B. Groenewald, MB, ChB,* James P. Moriarty, MSc, and Randall Flick, MD, MPH*
More informationPATIENT IDENTIFICATION POLICY
PATIENT IDENTIFICATION POLICY DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Effectiveness Committee Date ratified: 12 th January 2012 Name of originator/author: Clinical Policy Advisor Name of responsible
More informationSUCCESSION PLANNING: FILLING A LABORATORY DIRECTOR S SHOES PART ONE
JANUARY / FEBRUARY 09 SUCCESSION PLANNING: FILLING A LABORATORY DIRECTOR S SHOES PART ONE By Karen Appold When someone leaves a laboratory director position, or any job for that matter, it could be for
More informationThese incidents, reported by the Pennsylvania Patient Safety Authority, are
Patient safety Taking steps to protect patients from specimen-handling errors An OR specimen was transported to the laboratory. The lab called to say there was no specimen in the container. The specimen
More informationQuality Assurance Program For Hospital Based Point of Care Testing. Presented by: Jeanne Mumford, MT(ASCP) Pathology Supervisor, QA Specialist
Quality Assurance Program For Hospital Based Point of Care Testing Presented by: Jeanne Mumford, MT(ASCP) Pathology Supervisor, QA Specialist 1 Objectives At the end of the session, participants will be
More informationThe Impact of Pre Hospital Blood Collection on Time to Laboratory Test Results and Emergency Department Length of Stay
The Impact of Pre Hospital Blood Collection on Time to Laboratory Test Results and Emergency Department Length of Stay Improving the Odds on Quality Las Vegas, Nevada January 25 27, 2012 Principal Investigator:
More informationZebra Printing Solutions
healthcare Zebra Printing Solutions Getting Started on Barcode Adoption. Zebra barcoding helps healthcare facilities identify, track and manage people, processes and assets. Positive patient identification
More informationMedication Administration, Delivery and Reconciliation Systems
Medication Administration, Delivery and Reconciliation Systems Foundational Curricula: Cluster 5: EHR Systems Module 9: EHR Modules Medications, Allergies, Clinical Decision Support and Order Entry Unit
More informationNHS waiting times for elective care in England
Report by the Comptroller and Auditor General Department of Health NHS waiting times for elective care in England HC 964 SESSION 2013-14 23 JANUARY 2014 4 Key facts NHS waiting times for elective care
More informationCHALLENGES IN POCT. Dr. Jayesh P. Warade. Consultant Biochemistry and Quality Manager, Meenakshi Mission Hospital and Research Centre, Madurai, India
CHALLENGES IN POCT Dr. Jayesh P. Warade Consultant Biochemistry and Quality Manager, Meenakshi Mission Hospital and Research Centre, Madurai, India Abstract: Point of care testing (POCT) refers to testing
More informationBenefiting From Bedside Specimen Labeling
Benefiting From Bedside Specimen Labeling EXECUTIVE SUMMARY Labeling blood and other samples at the time they are collected improves patient safety and helps prevent a host of problems related to misidentification
More informationBLOOD TRANSFUSION POLICY
Title: BLOOD TRANSFUSION POLICY Ref: 0219 Version 11 Classification: Guideline Directorate: Laboratory Medicine Due for Review: 15/12/2020 Document Control Responsible Consultant Haematologist and Transfusion
More informationNicholas E. Davies Enterprise Award of Excellence Clinical Value
Applicant Organization: Centura Health Organization s Address: 188 Inverness Dr. W #500, Englewood, CO 80112 Submitter: Amy Feaster, Vice President of Information Technology Email: amyfeaster@centura.org
More informationParkland Health & Hospital System Department of Pathology Research Support
Parkland Health & Hospital System Department of Pathology Research Support The Road to Successful Request for Pathology Research Services Kim Coston, MT(AMT) Pathology Research & Client Services Coordinator
More informationAdministration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016
Administration of blood components Denise Watson Patient Blood Management Practitioner 11th January, 2016 Introduction British Committee for Standards in Haematology guidelines Administration process Case
More information01/12/14. Nomen Omen: Analytical performance goals Performance goals. Performance criteria. Quality specifications
Nomen Omen: Analytical performance goals Performance goals Performance criteria Quality specifications 1 The level of performance required to facilitate clinical decision-making. Callum G Fraser may we
More informationKorus Ordering Frequently Asked Questions
Korus Ordering DEMOGRAPHICS Q. How do I transfer patients to sister facilities? A. Patients can be transferred to a sister facility from Patient Registration. Starting on the Dashboard, enter the patient
More information